| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | — |
| Cost of Revenue | $10.8M | — |
| R&D Expense | $344.1M | +16.7% |
| SG&A Expense | $106.9M | +2.7% |
| Operating Income | -$460.6M | -15.5% |
| Pre-tax Income | -$447.5M | -13.0% |
| Income Tax | -$3.5M | — |
| Net Income | -$444.0M | -12.2% |
| EPS (Basic) | -$1.89 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $114.9M | -50.4% |
| Short-term Investments | $165.0M | -31.3% |
| Accounts Receivable | $151K | — |
| Inventory | $10.4M | — |
| Current Assets | $307.8M | -35.7% |
| Total Assets | $780.4M | +17.5% |
| Current Liabilities | $110.3M | +20.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$361.8M | -23.6% |
| Capital Expenditures | $22.3M | +9.1% |
| Investing Cash Flow | -$155.2M | -160.5% |
| Financing Cash Flow | $463.0M | +143.5% |
| Free Cash Flow | -$384.1M | -22.6% |
| +24.1% |
| EPS (Diluted) | -$1.89 | +24.1% |
| Total Liabilities |
| $195.7M |
| +19.1% |
| Stockholders' Equity | $584.6M | +17.0% |